The FDA has just authorized, for the first time, a direct-to-consumer (DTC) genetic test to report on three genetic variants found on BRCA1 and BRCA2 genes. These genetic variants are known to increase a person’s risk for developing primarily breast cancer, but also also ovarian or prostate cancers.
.. Continue Reading FDA approves, with reservations, the first home DNA test for genetic breast cancer risk
Category: Health & Wellbeing
Tags:
Related Articles:
- New Sema4 DNA test screens your child for 193 genetic diseases
- Ancient mummy DNA reveals surprises about genetic origins of Egyptians
- FDA approves home genetic tests for Alzheimer’s and other diseases
- FDA approves another gene therapy, this time for treating inherited vision loss
- Mutations in a single gene linked to severe obesity
- New CRISPR tools enable extraordinarily precise gene editing in human cells
